in , ,

Tru-D SmartUVC Locks in Disinfection Robot Agreement with HealthTrust

Tru-D SmartUVC LLC has announced an agreement with HealthTrust, which serves 1,350 acute care facilities and members in more than 15,000 locations.

Tru-D SmartUVC is a germ-eliminating UV disinfection robot used to kill germs and pathogens that plague health care environments. The device measures UVC dose and calculates the proper time needed to thoroughly deliver a measured dose of UV light from a single placement in the room.

The new agreement will allow Tru-D SmartUVC’s automated disinfection robot to be purchased and utilized by hospitals in the HealthTrust members that are committed to taking their infection prevention efforts to the next level.

“Hospitals are increasingly recognizing the need for an advanced and integrated approach to improving patient outcomes on several levels,” said Chuck Dunn, president and chief executive officer of Tru-D Smart UVC LLC. “Antibiotic resistant bacteria and HAIs are a challenge that cost health care facilities billions of dollars every year. By integrating advanced technology that has been proven as a solution time and time again, hospitals are not only saving money, but they are also protecting patients and staff from acquiring potentially deadly illnesses.”

HealthTrust members include acute, ambulatory surgery centers, physician practices, long-term care facilities and alternate care sites. With an established reputation in acute care facilities across the United States, Tru-D SmartUVC is now expanding access to other health care providers and facilities in the industry through this contractual partnership.

Third Party comparisons to pulsed xenon methods conclude Tru-D SmartUVC is six times more effective eliminating Clostridium difficile spores, seven times more effective removing vancomycin-resistant Enterococcus (VRE), and twice as effective against methicillin-resistant Staphylococcus aureus (MRSA).

Hundreds of Tru-Ds have been deployed to disinfect hospitals across the U.S., Canada, Europe and Africa, including the National Institutes of Health Clinical Center in Bethesda, Maryland; Nottingham University Hospitals NHS Trust’s QMC campus in Nottingham, England; and Ebola Treatment Units at ELWA Hospital and Island Hospital in Monrovia, Liberia.

Source: Tru-D SmartUVC press release, adapted.

Biodefense Headlines – Mar 22, 2015

Biodefense & Biosurveillance Digital Tools

BARDA Seeks 3D Visualization Hub for Emergency Response